Sick leave and occupational burnout among nurse practitioners caring for patients with multiple sclerosis (P3-4.001)

Resumen

Objective: To assess the presence of sick leave among nurse practitioners (NPs) caring for patients with multiple sclerosis (MS) and to identify associated factors.Background: Sick leave is a common problem among healthcare professionals. NPs play a critical role in the multidisciplinary management of MS. However, limited information is available on the frequency and factors involved in sick leave in MS nurses.Design/Methods: A multicenter, non interventional, cross-sectional, web-based study was conducted. NPs involved in the care of patients with MS were invited to participate in the study by the Spanish Society of Neurology Nursing (SEDENE). Participants answered a survey composed of demographic items, professional background, and questions about their standard practice. The Maslach Burnout Inventory - Human Services Survey (MBI-HSS) was used to assess emotional exhaustion related to work. A multivariable logistic regression analysis was conducted to determine the association between NPs’ characteristics and sick leave.Results: Ninety-six NPs were included in the study. Mean age (SD) was 44.6 (9.8) years and 91.7% were female. NPs had a mean of 7.5 (5.3) years of expertise in MS managing on average 23.9 (22.6) patients per week. 16.7% (n=16) of participants had been on sick leave in the last 6 months, with a median absence of 14.5 days (IQR 7, 30). Sixteen NPs (16.7%) reported severe burnout. Participants on sick leave had higher levels of emotional exhaustion than their counterparts (mean MBI-HSS scores 22.3 and 16.0, respectively; p=0.01). Burnout was associated with higher risk of sick leave in the multivariable analysis (OR=1.06 [95% CI 1.00, 1.13], p=0.04) after adjustment for confounders.Conclusions: Occupational burnout is associated with increased risk of sick leave among NPs managing patients with MS. Identifying burnout may be critical for implementing specific intervention strategies to optimize the management of patients at MS clinics.Disclosure: Dr. Saposnik has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Saposnik has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene. Dr. Saposnik has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Servier. Dr. Saposnik has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NIHSS. The institution of Dr. Saposnik has received research support from Roche. The institution of Dr. Saposnik has received research support from Heart and Stroke Foundation of Canada. Mr. Bueno has received personal compensation for serving as an employee of Roche . Miss Rios has nothing to disclose. haydee goicochea briceño has received personal compensation in the range of $0-$499 for serving as a Consultant for Merck. haydee goicochea briceño has received personal compensation in the range of $0-$499 for serving as a Consultant for Roche. haydee goicochea briceño has received personal compensation in the range of $0-$499 for serving as a Consultant for Almirrall. haydee goicochea briceño has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer. haydee goicochea briceño has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Novartis. haydee goicochea briceño has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Teva. haydee goicochea briceño has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Merk. haydee goicochea briceño has received research support from IOMSN. Mrs. Ocaña has nothing to disclose. Mr. Franco has nothing to disclose. Dr. Medrano has nothing to disclose. Jorge Maurino has received personal compensation for serving as an employee of Roche Pharma Spain, Medical Department.